Yahoo Web Search

Search results

  1. Ambrx (NYSE: AMAM), a clinical stage biopharmaceutical company using an expanded genetic code technology platform to create Engineered Precision Biologics, today announced the appointment of Sonja Nelson to Chief Financial Officer.

    • Sonja Nelson

      Sonja Nelson has served as our Chief Financial Officer since...

  2. ambrx.com › team › sonja-nelsonSonja Nelson | Ambrx

    Oct 11, 2023 · Sonja Nelson has served as our Chief Financial Officer since June 2021. An experienced financial executive, Ms. Nelson joined Ambrx with 10 years of executive experience within the biotechnology industry.

  3. Jun 30, 2021 · SAN DIEGO-- ( BUSINESS WIRE )-- Ambrx (NYSE: AMAM), a clinical stage biopharmaceutical company using an expanded genetic code technology platform to create Engineered Precision Biologics, today...

  4. Oct 28, 2021 · In June, Sonja Nelson joined Ambrx as its Chief Financial Officer. Ms. Nelson is an experienced financial executive, who joined Ambrx with 10 years of executive experience within the...

  5. View Sonja Nelsons profile on LinkedIn, a professional community of 1 billion members. Experienced and driven financial and corporate leader with demonstrated history of…

    • 500+
    • Ambrx
    • 1K
    • San Diego, California, United States
  6. Jun 23, 2021 · Motus GI Appoints Experienced Financial Biotech Executive, Sonja Nelson, to its Board of Directors and as Chair of Audit Committee. Motus GI Holdings, Inc. Wed, Jun 23, 2021, 4:05 PM 3 min...

  7. Sonja Nelson is Chief Financial Officer at Ambrx Biopharma Inc. See Sonja Nelson's compensation, career history, education, & memberships.